InsidersTradesSigma
Track the Aclarion, Inc. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Operating in the Technology sector, Aclarion, Inc. has recorded 29 insider filings. Market capitalisation: €133.5bn. The latest transaction was disclosed on 19 August 2026 (Acquisition). Among the most active insiders: Neal David K. The full history is accessible without an account.
29
Insider Decl.
n/a
Thresholds
€372,337
16 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Aclarion, Inc. Strong Buy (bullish), based on 43 analysts. Average price target: US$1,501.98.
61Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,963 of 29,056 companies
4.2
score / 100
Value1
Quality7
FCF yld-109%
Earn yld-107%
EV/EBITDA·
ROE-59%
Gross mgn9.0%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 19 August 2026
Declarations29 total
5,857 shares@ US$2.73Common StockSEC:0001683168-26-006576:0
Canonical exit: 15 Nov 2026 (T+90)
10,000 shares@ US$2.450.0000% mcap100.0% of flowCommon StockSEC:0001683168-26-006545:0
Canonical exit: 12 Nov 2026 (T+90)
5,234 shares@ US$2.310.0000% mcap67.8% of flowCommon StockSEC:0001683168-26-006512:0
Canonical exit: 11 Nov 2026 (T+90)
7,500 shares@ US$2.400.0000% mcap9.7% of flowCommon StockSEC:0001683168-26-006513:0
Canonical exit: 11 Nov 2026 (T+90)
2,150 shares@ US$2.340.0000% mcap9.0% of flowCommon StockSEC:0001683168-26-006514:0
Canonical exit: 11 Nov 2026 (T+90)
20,000 sharesCommon StockSEC:0001683168-26-004812:0
20,000 sharesCommon StockSEC:0001683168-26-004806:0
100,000 sharesCommon StockSEC:0001683168-26-004807:0
20,000 sharesCommon StockSEC:0001683168-26-004809:0
20,000 sharesCommon StockSEC:0001683168-26-004810:0
100,000 sharesCommon StockSEC:0001683168-26-004811:0
20,000 sharesCommon StockSEC:0001683168-26-004814:0
50,000 sharesCommon StockSEC:0001683168-26-004813:0
5,664 shares@ US$3.180.0000% mcap100.0% of flowCommon StockSEC:0001683168-26-003744:0
Canonical exit: 10 Aug 2026 (T+90)
2,500 shares@ US$3.100.0000% mcap4.5% of flowCommon StockSEC:0001683168-26-003694:0
Canonical exit: 9 Aug 2026 (T+90)
10 shares@ US$6.201.1% of flowCommon StockSEC:0001683168-25-008777:0
Canonical exit: 24 Feb 2026 (T+90)
1 shares@ US$1,000.0049.7% of flowSeries A Preferred StockSEC:0001683168-23-001855:0
1 shares@ US$1,000.0050.3% of flowSeries A Preferred StockSEC:0001683168-23-001067:0
Canonical exit: 17 May 2023 (T+90)
4,100 shares@ US$0.43100.0% of flowCommon StockSEC:0001683168-22-008686:0
Canonical exit: 29 Mar 2023 (T+90)
2,289 shares@ US$0.4218.4% of flowCommon StockSEC:0001683168-22-008688:0
Canonical exit: 28 Mar 2023 (T+90)
152,128 shares0Common StockSEC:0001683168-22-008267:0
1,091,894 shares0Common StockSEC:0001683168-22-008227:0
152,128 shares0Common StockSEC:0001683168-22-008226:0
25 of 29 declarations
About Aclarion, Inc.
Aclarion, Inc. is a technology company focused on developing health solutions based on artificial intelligence. It aims to improve clinical outcomes through advanced analytics.